744 related articles for article (PubMed ID: 16715088)
1. Generation of C5a in the absence of C3: a new complement activation pathway.
Huber-Lang M; Sarma JV; Zetoune FS; Rittirsch D; Neff TA; McGuire SR; Lambris JD; Warner RL; Flierl MA; Hoesel LM; Gebhard F; Younger JG; Drouin SM; Wetsel RA; Ward PA
Nat Med; 2006 Jun; 12(6):682-7. PubMed ID: 16715088
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.
Kievits F; Kijlstra A
Immunology; 1985 Mar; 54(3):449-56. PubMed ID: 3844370
[TBL] [Abstract][Full Text] [Related]
3. The role of C5a in the innate immune response after experimental blunt chest trauma.
Flierl MA; Perl M; Rittirsch D; Bartl C; Schreiber H; Fleig V; Schlaf G; Liener U; Brueckner UB; Gebhard F; Huber-Lang MS
Shock; 2008 Jan; 29(1):25-31. PubMed ID: 17621257
[TBL] [Abstract][Full Text] [Related]
4. Generation of complement fragment C5a in milk is variable among cows.
Rainard P; Poutrel B
J Dairy Sci; 2000 May; 83(5):945-51. PubMed ID: 10821569
[TBL] [Abstract][Full Text] [Related]
5. Complement activation in cystic fibrosis respiratory fluids: in vivo and in vitro generation of C5a and chemotactic activity.
Fick RB; Robbins RA; Squier SU; Schoderbek WE; Russ WD
Pediatr Res; 1986 Dec; 20(12):1258-68. PubMed ID: 3540828
[TBL] [Abstract][Full Text] [Related]
6. Relative inefficiency of terminal complement activation.
Bhakdi S; Fassbender W; Hugo F; Carreno MP; Berstecher C; Malasit P; Kazatchkine MD
J Immunol; 1988 Nov; 141(9):3117-22. PubMed ID: 3262681
[TBL] [Abstract][Full Text] [Related]
7. Complement mediates a primed inflammatory response after traumatic lung injury.
Hoth JJ; Wells JD; Jones SE; Yoza BK; McCall CE
J Trauma Acute Care Surg; 2014 Mar; 76(3):601-8; discussion 608-9. PubMed ID: 24553525
[TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of endogenous protease inhibitors in acute lung inflammatory injury.
Gipson TS; Bless NM; Shanley TP; Crouch LD; Bleavins MR; Younkin EM; Sarma V; Gibbs DF; Tefera W; McConnell PC; Mueller WT; Johnson KJ; Ward PA
J Immunol; 1999 Mar; 162(6):3653-62. PubMed ID: 10092827
[TBL] [Abstract][Full Text] [Related]
9. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
[TBL] [Abstract][Full Text] [Related]
10. Thrombin-activatable fibrinolysis inhibitor protects against acute lung injury by inhibiting the complement system.
Naito M; Taguchi O; Kobayashi T; Takagi T; D'Alessandro-Gabazza CN; Matsushima Y; Boveda-Ruiz D; Gil-Bernabe P; Matsumoto T; Chelakkot-Govindalayathil AL; Toda M; Yasukawa A; Hataji O; Morser J; Takei Y; Gabazza EC
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):646-53. PubMed ID: 23721130
[TBL] [Abstract][Full Text] [Related]
11. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
12. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
13. Targeting complement component 5a promotes vascular integrity and limits airway remodeling.
Khan MA; Maasch C; Vater A; Klussmann S; Morser J; Leung LL; Atkinson C; Tomlinson S; Heeger PS; Nicolls MR
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6061-6. PubMed ID: 23530212
[TBL] [Abstract][Full Text] [Related]
14. Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways.
Wust SK; Blumenthal MN; Corazalla EO; Benson BA; Dalmasso AP
Transl Res; 2006 Oct; 148(4):157-63. PubMed ID: 17002917
[TBL] [Abstract][Full Text] [Related]
15. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcgammaRs in immune complex-induced lung disease.
Shushakova N; Skokowa J; Schulman J; Baumann U; Zwirner J; Schmidt RE; Gessner JE
J Clin Invest; 2002 Dec; 110(12):1823-30. PubMed ID: 12488432
[TBL] [Abstract][Full Text] [Related]
16. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.
Pierangeli SS; Girardi G; Vega-Ostertag M; Liu X; Espinola RG; Salmon J
Arthritis Rheum; 2005 Jul; 52(7):2120-4. PubMed ID: 15986360
[TBL] [Abstract][Full Text] [Related]
17. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
Møller-Kristensen M; Thiel S; Sjöholm A; Matsushita M; Jensenius JC
Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
[TBL] [Abstract][Full Text] [Related]
18. [Complement activation and inflammation].
Abe M
Rinsho Byori; 2006 Jul; 54(7):744-56. PubMed ID: 16913666
[TBL] [Abstract][Full Text] [Related]
19. Complement component c5a is integral to the febrile response of mice to lipopolysaccharide.
Li S; Boackle SA; Holers VM; Lambris JD; Blatteis CM
Neuroimmunomodulation; 2005; 12(2):67-80. PubMed ID: 15785108
[TBL] [Abstract][Full Text] [Related]
20. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.
Pickering MC; Cook HT; Warren J; Bygrave AE; Moss J; Walport MJ; Botto M
Nat Genet; 2002 Aug; 31(4):424-8. PubMed ID: 12091909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
